Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial.
Jean-Louis Pujol
No relevant relationships to disclose
Armelle Lavole
No relevant relationships to disclose
Bertrand Mennecier
No relevant relationships to disclose
Oliver Molinier
No relevant relationships to disclose
Pierre Jean Souquet
No relevant relationships to disclose
Fabrice Barlesi
No relevant relationships to disclose
Herve Le Caer
No relevant relationships to disclose
Denis Moro-Sibilot
No relevant relationships to disclose
Pierre Fournel
No relevant relationships to disclose
Jean-Philippe Oster
No relevant relationships to disclose
Patrick Chatellain
No relevant relationships to disclose
Patricia Barre
No relevant relationships to disclose
Gaelle Jeannin
No relevant relationships to disclose
Pierre Mourlanette
No relevant relationships to disclose
Marc Derollez
No relevant relationships to disclose
Dominique Herman
No relevant relationships to disclose
Patrick Renault
No relevant relationships to disclose
Charles Dayen
No relevant relationships to disclose
Franck Morin
No relevant relationships to disclose
Gerard Zalcman
No relevant relationships to disclose